HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ridha Joober Selected Research

Polytetrafluoroethylene (Teflon)

12/2022Young Adults' Perspectives on Factors Related to Relapse After First-Episode Psychosis: Qualitative Focus Group Study.
11/2022A polymorphism in the glutamate metabotropic receptor 7 is associated with cognitive deficits in the early phases of psychosis.
7/2022An observational study of antipsychotic medication discontinuation in first-episode psychosis: clinical and functional outcomes.
4/2022Severe childhood trauma and emotion recognition in males and females with first-episode psychosis.
1/2022Manualized group cognitive behavioral therapy for social anxiety in first-episode psychosis: a randomized controlled trial.
1/2022Dynamic Interplay Between Insight and Persistent Negative Symptoms in First Episode of Psychosis: A Longitudinal Study.
1/2022Measurement Based Care in a first episode psychosis program: Development of an algorithm of care based on the Clinical Global Impressions Scale.
1/2022Normal-range verbal memory in the first-episode of psychosis: Clinical and functional outcomes across 24 months and impact of estimated verbal memory decrement.
1/2022Sex-specific associations in verbal memory brain circuitry in early psychosis.
12/2021A Digital Health Innovation to Prevent Relapse and Support Recovery in Youth Receiving Specialized Services for First-Episode Psychosis: Protocol for a Pilot Pre-Post, Mixed Methods Study of Horyzons-Canada (Phase 2).
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ridha Joober Research Topics

Disease

95Psychotic Disorders (Schizoaffective Disorder)
12/2022 - 12/2005
46Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2022 - 01/2003
20Schizophrenia (Dementia Praecox)
11/2022 - 09/2002
7Feeding and Eating Disorders (Eating Disorder)
06/2022 - 08/2005
7Mental Disorders (Mental Disorder)
01/2022 - 08/2006
6Bulimia Nervosa
10/2014 - 01/2005
6Bulimia (Binge Eating)
01/2014 - 01/2005
5Weight Gain
01/2019 - 01/2004
5Substance-Related Disorders (Drug Abuse)
06/2016 - 06/2008
5Autistic Disorder (Autism)
11/2013 - 01/2005
4Cognitive Dysfunction
11/2022 - 01/2014
3Anxiety Disorders (Anxiety Disorder)
01/2017 - 06/2008
3Borderline Personality Disorder (Personality Disorders, Borderline)
10/2014 - 01/2005
3Intellectual Disability (Idiocy)
11/2013 - 12/2008
2Sleep Wake Disorders
11/2022 - 05/2017
2Dyslipidemias (Dyslipidemia)
01/2021 - 01/2020
2Insulin Resistance
01/2021 - 07/2008
2Autism Spectrum Disorder
05/2020 - 01/2019
2Alzheimer Disease (Alzheimer's Disease)
01/2018 - 01/2016
2Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 05/2012
2Learning Disabilities (Learning Disability)
07/2015 - 01/2006
2Cerebral Cortical Thinning
01/2014 - 01/2014
2Mood Disorders (Mood Disorder)
10/2013 - 01/2005
2Major Depressive Disorder (Major Depressive Disorders)
03/2013 - 06/2008
1Psychomotor Agitation (Akathisia)
11/2022
1Alcoholism (Alcohol Abuse)
11/2022
1Anorexia Nervosa
06/2022
1Wounds and Injuries (Trauma)
04/2022
1Memory Disorders (Memory Loss)
01/2022
1Serotonin Syndrome (Syndrome, Serotonin)
01/2021
1Atrophy
01/2018
1Sleep Initiation and Maintenance Disorders (Insomnia)
05/2017
1Catatonia
10/2016
1Epilepsy (Aura)
11/2013
1Megalencephaly
11/2013
1Tuberous Sclerosis (Bourneville's Disease)
11/2013
1Hamartoma
11/2013
1Oppositional Defiant Disorder
01/2013

Drug/Important Bio-Agent (IBA)

85Polytetrafluoroethylene (Teflon)FDA Link
12/2022 - 12/2005
26Methylphenidate (Ritalin)FDA LinkGeneric
01/2021 - 05/2004
19Antipsychotic Agents (Antipsychotics)IBA
11/2022 - 02/2003
12Dopamine (Intropin)FDA LinkGeneric
10/2021 - 01/2003
62- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
10/2020 - 03/2005
5Hydrocortisone (Cortisol)FDA LinkGeneric
01/2019 - 06/2008
5Proteins (Proteins, Gene)FDA Link
11/2013 - 01/2005
5Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
09/2012 - 01/2003
4Pharmaceutical PreparationsIBA
11/2022 - 12/2005
4Biological ProductsIBA
10/2020 - 09/2002
4Clozapine (Clozaril)FDA LinkGeneric
01/2018 - 01/2004
4Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
04/2014 - 12/2004
4Serotonin (5 Hydroxytryptamine)IBA
06/2010 - 01/2005
3DNA (Deoxyribonucleic Acid)IBA
06/2022 - 06/2009
3Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2018
3LipidsIBA
01/2020 - 12/2005
3Aripiprazole (Abilify)FDA Link
01/2019 - 01/2016
3Apolipoproteins E (ApoE)IBA
01/2018 - 06/2008
3Nonsense Codon (Nonsense Mutation)IBA
01/2015 - 11/2010
3Brain-Derived Neurotrophic Factor (BDNF)IBA
10/2014 - 03/2009
3Amphetamine (Amfetamine)FDA LinkGeneric
05/2014 - 01/2004
3Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
01/2011 - 06/2008
2Olanzapine (Zyprexa)FDA Link
01/2019 - 12/2005
2Dopamine Receptors (Dopamine Receptor)IBA
01/2019 - 01/2003
2CDRI 85-287 (PEPP)IBA
12/2018 - 01/2017
2EnzymesIBA
12/2014 - 01/2011
2Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
02/2012 - 05/2011
2Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA
02/2012 - 01/2012
23' Untranslated Regions (3' UTR)IBA
06/2008 - 01/2005
2Paroxetine (Paxil)FDA LinkGeneric
08/2006 - 01/2005
1Glutamic Acid (Glutamate)FDA Link
11/2022
1N-Methylaspartate (NMDA)IBA
11/2022
1AdipokinesIBA
01/2021
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
01/2021
1CannabidiolIBA
01/2021
1Pregabalin (Lyrica)FDA Link
01/2020
1Norepinephrine (Noradrenaline)FDA LinkGeneric
10/2019
1Risperidone (Risperdal Consta)FDA LinkGeneric
01/2019
1Indicators and Reagents (Reagents)IBA
01/2019
1SolutionsIBA
11/2018
1Apolipoprotein E4IBA
01/2018
1DCC ReceptorIBA
01/2018
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2018
1Eszopiclone (Lunesta)FDA Link
05/2017
1MelatoninIBA
05/2017
1CatecholaminesIBA
01/2017
1Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
01/2016
1ApolipoproteinsIBA
01/2016
1Histone Deacetylases (Histone Deacetylase)IBA
12/2014
1Histones (Histone)IBA
12/2014
1RacloprideIBA
05/2014
1LactoseFDA LinkGeneric
05/2014
1Dextroamphetamine (Dexedrine)FDA LinkGeneric
05/2014
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
01/2014
1Mechanistic Target of Rapamycin Complex 1IBA
11/2013
1trans-sodium crocetinate (crocetin)IBA
11/2013
1Oxytocin (Pitocin)FDA LinkGeneric
03/2013

Therapy/Procedure

3Therapeutics
01/2016 - 01/2009
1Precision Medicine
11/2022
1Treatment Delay
01/2022
1Glycemic Control
01/2018
1Drug Therapy (Chemotherapy)
05/2017